Drug Topics August 19, 2025
In the context of the COVID-19 pandemic, researchers investigated how insulin use and glycemic control were associated among patients with type 2 diabetes.
Consistent insulin therapy has the potential for significantly maintaining glycemic control during health care disruptions such as the COVID-19 pandemic, according to a study published in Pharmacy (Basel).1 Researchers’ findings show that the integration of telehealth and pharmacist-led interventions can bolster diabetes care during major health care emergencies.
“The onset of the COVID-19 pandemic in March 2020 triggered widespread disruptions across health care systems worldwide, posing challenges for individuals managing type 2 diabetes (T2D),” wrote authors of the study. “The implementation of public health measures, including lockdowns and social distancing protocols, potentially hindered access to routine medical...
Today's Sponsors
Today's Sponsor